Hetero Labs
-
GSK to sell Vemgal facility to Hetero Labs for Rs 180 crore
The transaction is expected to be completed by September 30, 2021 GlaxoSmithKline Pharmaceuticals (GSK) said its board has approved the…
Read More »
The transaction is expected to be completed by September 30, 2021 GlaxoSmithKline Pharmaceuticals (GSK) said its board has approved the…
Read More »